These two targets have a few interacting proteins in common such as TIMP (1, 2 and 3), STAT 3, VEGF A, SRC, DCN, MMP 10 and CD 44 (Fig. S8) and all are supposed to be plum targets for cancer therapies. The gene discussed is MMP10; the disease is cancer.